Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)

Last updated: August 26, 2024
Sponsor: Orygen
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)

Clinical Study ID

NCT06463470
ORY-P02-24-04
  • Ages 12-25
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

CBT-AR describes an adaption of cognitive behavioural therapy for use with individuals diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID). The purpose of this evaluation is to determine the feasibility, acceptability and effectiveness of this treatment.

It is hypothesised that this treatment will be feasible and acceptable to clinicians, carers and patients and will be effective in reducing symptoms of ARFID for patients.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Current primary diagnosis of ARFID according to DSM-5 criteria as determined by thetreating team (the eating disorders Orygen Specialist Program

  • Presenting for treatment in the eating disorders Orygen Specialist Program

  • If <16yo, or >16 but underweight (BMI <18.5) and living with their parents/guardian,a parent/guardian should be involved in the treatment.

Exclusion

Exclusion Criteria:

  • Current tube feeding

  • Inappropriateness for CBT-AR as determined by the clinicians (e.g. if there are moreurgent issues to first manage such as high suicidal ideation, if participants do nothave adequate comprehension capability, etc)

Study Design

Total Participants: 20
Treatment Group(s): 1
Primary Treatment: Cognitive Behavioural Therapy for Avoidant/Restrictive Food Intake Disorder (CBT-AR)
Phase:
Study Start date:
June 27, 2024
Estimated Completion Date:
March 31, 2026

Study Description

CBT-AR describes an adaption of cognitive behavioural therapy that is appropriate for use with individuals diagnosed with Avoidant/Restrictive Food Intake Disorder (ARFID). This therapy will be delivered by trained clinicians (e.g. psychologists, mental health nurses) and involves weekly sessions for 18-30 sessions (up to 30 sessions for underweight patients). This therapy will be delivered face-to-face whenever possible. If required (participant not able to travel for a session etc.) online or telephone sessions will be conducted.

This therapy involves four stages as described below.

  • Stage 1 - Psychoeducation: This is covered in 2-4 sessions and involves explaining what ARFID is, educating patients and carers on food groups, nutrition and how to develop a balanced diet. Work is also done to increase eating volume for those who are underweight.

  • Stage 2 - Treatment planning: This is covered in 2 sessions and involves matching the individuals needs to the correct exposure approach (examples provided in stage 3).

  • Stage 3 - Graded exposure is covered for between 12 and 22 sessions (depending on the patient's needs) and describes slowly introducing more variety and volume of foods into the patient's diet. For those patients who are uncomfortable with strong tastes and textures, graded exposure might involve eating very small amounts of new foods during which time they are encouraged to describe the look, feel and taste of the food using neutral words to reduce a negative response. If they have a fear of choking, they might start by talking about that fear, followed by watching a video of someone choking and recovering, then they might eat a very small amount of food to reduce the risk of choking, followed by increases in portions over time.

  • Stage 4 - Relapse prevention: This is covered in 2 sessions. In these sessions, individuals are taught to recognise triggers and indicators of relapse. They are then able to go back to the materials provided in treatment to guide their management of these relapsing thoughts/behaviours.

Clinicians will collect data on adherence weekly. A measure of patient, parent/guardian and clinician satisfaction will be collected at the end of stage 4.

Parents/guardians of individuals <16yrs, or parents/guardians of patients who are underweight and living at home irrespective of age are involved in therapy through attending psychoeducation sessions and supporting the completion of homework.

Connect with a study center

  • Orygen Youth Health - Parkville - Parkville

    Melbourne, Victoria 3052
    Australia

    Active - Recruiting

  • Orygen Youth Health - Sunshine - Sunshine

    Melbourne, Victoria 3020
    Australia

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.